PODD - Insulet raises 2025 revenue guidance to 19%-22% growth amid strong Omnipod adoption
2025-05-08 22:35:46 ET
More on Insulet
- Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript
- Insulet Leans Bullish (Technical Analysis)
- Insulet: Aiding Patients And Investors
- Insulet Non-GAAP EPS of $1.02 beats by $0.23, revenue of $569M beats by $25.7M
- Insulet Q1 2025 Earnings Preview